Key result
Higher STS-EACTS complexity is linked to ~38% higher postoperative total cfDNA per category.
Why the study?
Circulating cell-free DNA rises after paediatric cardiac surgery and is linked to adverse outcomes, but its relationship with procedural complexity and the STS-EACTS mortality category throughout the perioperative period was unknown.
Does higher surgical complexity (STS-EACTS mortality category) increase perioperative total and cardiomyocyte-derived cell-free DNA concentrations in children undergoing cardiac surgery with cardiopulmonary bypass?
Cohort (n=50)
No
Does higher surgical complexity (STS-EACTS mortality category) increase perioperative total and cardiomyocyte-derived cell-free DNA concentrations in children undergoing cardiac surgery with cardiopulmonary bypass?
In pediatric cardiac surgery, total circulating cell-free DNA correlates strongly with surgical complexity both pre- and postoperatively, whereas cardiomyocyte-derived cfDNA is independent of procedural complexity and may specifically reflect direct myocardial injury.
Answers are grounded in this paper and cite their sources.
Total cfDNA may track perioperative stress by complexity in pediatric cardiac surgery; extends prior cfDNA data but leaves cardiomyocyte specificity for injury open.
OBJECTIVES Circulating cell-free Deoxyribonucleic Acid (cfDNA) rises after paediatric cardiac surgery and has been linked to adverse outcomes, but its relationship with procedural complexity is unknown. We examined whether total and cardiomyocyte-derived cfDNA are associated with the Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery (STS-EACTS) mortality category throughout the perioperative period. METHODS This was a secondary analysis of a prospective cohort of 50 children undergoing cardiac surgery with cardiopulmonary bypass. Total and cardiac-specific (methylation-based) cfDNA were measured before surgery and 0, 6, 12 and 24 h after bypass. Associations with STS-EACTS category (1–5) were estimated with linear mixed-effects models of log-transformed cfDNA adjusted for age, supported by per-time-point regressions with false-discovery-rate correction. RESULTS STS-EACTS categories were 1–2 in 20 (40%), 3 in 9 (18%) and 4–5 in 21 (42%) patients. Each one-category increase was associated with 30–47% higher total cfDNA across time points (overall P = 0.022; time interaction P = 0.89), including before surgery (geometric mean ratio [GMR] 1.30, 95% CI 1.01–1.66). After adjustment for preoperative levels, postoperative total cfDNA remained 38% higher per category (GMR 1.38, 95% CI 1.13–1.68; P = 0.001), most clearly at 12 and 24 h. The immediate bypass-related rise was not associated with complexity. Cardiac-specific cfDNA was not associated with STS-EACTS category at any time point (overall P = 0.90). CONCLUSIONS Higher surgical complexity is associated with persistently higher total, but not cardiomyocyte-derived, cfDNA, from before surgery through 24 h after bypass. Studies of cfDNA as a perioperative biomarker should account for procedural complexity.
No takes yet. Share an insight, caveat, or question.
Keizman et al. (2026) conducted a cohort in Congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass (n=50). STS-EACTS mortality category (1-5) vs. Lower STS-EACTS mortality category (per 1-category increase) was evaluated on Postoperative total circulating cell-free DNA (0-24 h) adjusted for preoperative concentration (GMR 1.38, 95% CI 1.13-1.68, p=0.001). Higher STS-EACTS surgical complexity was associated with 38% higher postoperative total cfDNA per category, but not with cardiomyocyte-derived cfDNA.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: